Transdermal Diagnostics
PrivateLast Round
Accelerator
Sep 18, 2025
Total Funding Raised
$2.27M
Company Overview
Transdermal Diagnostics operates in Healthcare & Life Sciences and is based in Bristol. Its latest recorded funding round was a Grant round in February 2025.
Transdermal Diagnostics is a medical technology company that develops a wearable, needle-free continuous glucose monitoring device for the management of diabetes and other chronic conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2C
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transdermal Diagnostics Comparables
Compare Transdermal Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Afon Technology | 88% | |
| One Health Biosensing Inc. | 85% | |
| GlucoModicum | 84% |
For institutional investors. Book with your work email.
Transdermal Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 18, 2025 | ||||
| Grant | Feb 4, 2025 | ||||
| Seed | Sep 6, 2022 | ||||
| Grant | Sep 6, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Transdermal Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QUBIS | Seed |
| SBRI Healthcare | Grant |
| Health Innovation Network | Grant |
| Pioneer Group | Seed |
| Bristol Private Equity Club | Seed |
| Immetric | Seed |
| Innovate UK | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 18, 2025
Received funding from University of Edinburgh AI Accelerator.
- May 3, 2025
Monthly visitors increased 36% MoM, reaching 417.
For institutional investors. Book with your work email.
Transdermal Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Transdermal Diagnostics's valuation, stock price, and market status.
Is Transdermal Diagnostics a public or private company?
Transdermal Diagnostics is a private company.
What is the current stock price of Transdermal Diagnostics?
Transdermal Diagnostics is a private company, so its shares have no public market price. Caplight tracks Transdermal Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Transdermal Diagnostics worth (valuation)?
Valuation information for Transdermal Diagnostics is not publicly available.
Can I buy Transdermal Diagnostics stock?
Transdermal Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Transdermal Diagnostics's last funding round?
Transdermal Diagnostics's most recent funding round was Accelerator on September 18, 2025.
Who are the main investors in Transdermal Diagnostics?
Key investors in Transdermal Diagnostics include QUBIS.
Will Transdermal Diagnostics IPO soon?
No public IPO plans have been announced for Transdermal Diagnostics.
How can I track Transdermal Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Transdermal Diagnostics's shares on secondary markets.